News and Press Releases
Press releases
Theralase Increases Revenue 14% in 3Q2016
Press ReleaseToronto, Ontario – November 29, 2016, Theralase Technologies Inc. (“Theralase®” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotech company focused on the commercialization of medical devices to eliminate pain and the ...
Theralase Announces Completion of Public Offering of Units
Press ReleaseNot for distribution to U.S. news wire services or dissemination in the United States. Toronto, Ontario – November 10, 2016 – Theralase Technologies Inc. (“Theralase” or the “Corporation”) (TSXV:TLT) (OTC Pink®: TLTFF) is ple...
Theralase Announces Proposed Public Offering of Units
Press ReleaseNot for distribution to U.S. news wire services or dissemination in the United States. Toronto, Ontario – November 7, 2016, Theralase Technologies Inc. (“Theralase” or the “Corporation”) (TSXV:TLT) (OTC Pink®: TLFF) is pleas...
Theralase Announces Filing of Amended and Restated Financial Statements for the Quarter Ended June 30, 2016
Press ReleaseToronto, Ontario – November 3, 2016 – Theralase Technologies Inc. (“Theralase” or the “Corporation”) (TLT:TSXV) (TLTFF:OTC), a leading biotech company focused on the commercialization of medical devices to eliminate pain and th...
Theralase Provides Clarification Regarding Certain Forward-Looking Information
Press ReleaseToronto, Ontario – November 1, 2016 – Theralase Technologies Inc. (“Theralase” or the “Corporation”) (TLT:TSXV) (TLTFF:OTC), a leading biotech company focused on the commercialization of medical devices to eliminate pain and th...
Theralase Increases GBM Brain Cancer Survival by 925%
Press ReleaseToronto, Ontario – October 28, 2016, Theralase Technologies Inc. (“Theralase®” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotech company focused on the commercialization of medical laser systems to eliminate pain and...
Theralase Anti-Cancer Technology to be Presented at International Conference
Press ReleaseToronto, Ontario – October 25, 2016, Theralase Technologies Inc. (“Theralase®” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotech company focused on the commercialization of medical devices to eliminate pain and th...
Health Canada Grants Theralase ITA Approval
Press ReleaseToronto, Ontario – October 20, 2016, Theralase Technologies Inc. (“Theralase®” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotech company focused on the commercialization of medical devices to eliminate pain and the d...
Theralase Demonstrates Significant Increase in Survival for Brain Cancer
Press ReleaseToronto, Ontario – October 13, 2016, Theralase Technologies Inc. (“Theralase®” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotech company focused on the commercialization of medical devices to eliminate pain and the d...
Theralase Provides Update on ITA Application to Health Canada
Press ReleaseToronto, Ontario – October 5, 2016, Theralase Technologies Inc. (“Theralase®” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotech company focused on the commercialization of medical devices to eliminate pain and the de...
in the news
July 6, 2023
Vrian Crombie Radio Interview with Roger DuMoulin-White - President and Chief Executive Officer
may 18, 2023
Promising Developments in the Theralase® Project of Intravesical Photodynamic Therapy for BCG Unresponsive Bladder Cancer - Girish Kulkarni
Let's Stay in Touch
Sign up to our newsletter to stay informed on news and updates from Theralase Technologies Inc.
